Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
Navigating Technology Transfer
Changing Column Packing from an Art into a Science
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
View All Featured ArticlesHeadline News
ORZEYFUL approved in Japan as the first and only medicine to address the underlying cause of narcolepsy type 1
Merck and Moderna’s Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA meets endpoints for recurrence-free survival and distant metastasis-free survival in patients with completely resected stage IIB-IV melanoma
Abbott reaches settlement agreements resolving portion of litigation tied to specialty formulas for preterm infants
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Biopharmaceutical process development – Trends/ Challenges/Opportunities
Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd and Sudhakar Nagaraj, Principal Scientist, SLS – Global Regulatory and Validation Consulting group at Pall Biotech
20th November 2019
Managing Biologics Process Analytical Technology in Pfizer
Presented by Keith Davis, Principle Scientist at Pfizer
12th March 2019
A Versatile Solution for Host Cell Proteins (HCPs) and Aggregates Removal for mAbs Purification
Presented by Catherine Allioux & Gareth Leach, Ph.D
08th June 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Amsphere TM A3
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
